Company profile
IGC PHARMA, INC.
AMEX:IGCBiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05543681 | phase2 | active_not_recruiting | 2022-10-11 | 2026-11-01 | IGC Pharma, LLC | Clinical Trial on Agitation in Alzheimer's Dementia |
| NCT04749563 | phase1 | completed | 2021-01-11 | 2021-06-20 | IGC Pharma, LLC | Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease |
FDA applications (0)
No records yet.